James J. Vaughn, Chief Commercial Officer at GENOMIC HEALTH INC (GHDX), sold 25,000 shares at $64.98 ($1.6M) on 2018-10-08, disclosed to the SEC on 2018-10-10.
Open-market sale of $1.6M GHDX by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $64.98 | 16,215 | $1.1M | 64.5% |
| 2 | $65.82 | 6,310 | $415K | 25.4% |
| 3 | $66.52 | 2,475 | $165K | 10.1% |
| Total | $65.34 avg | 25,000 | $1.6M | 100% |
| Filing → |
| GHDX | SELL | 2019-09-11 | $311K | — | Filing → |
| GHDX | SELL | 2019-08-12 | $332K | — | Filing → |
| GHDX | SELL | 2019-08-12 | $273K | — | Filing → |